Promethazine Hydrochloride Syrup
NDC Package 27808-051-01
Package Information
Promethazine Hydrochloride syrups is promethazine Hydrochloride Syrup (Promethazine Hydrochloride Oral Solution, USP) is useful for:Perennial and seasonal allergic rhinitis.Vasomotor rhinitis.Allergic conjunctivitis due to inhalant allergens and foods.Mild, uncomplicated allergic skin manifestations of urticaria and angioedema.Amelioration of allergic reactions to blood or plasma.Dermographism.Anaphylactic reactions, as adjunctive therapy to epinephrine and other standard measures, after the acute manifestations have been controlled.Preoperative, postoperative, or obstetric sedation.Prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery.Therapy adjunctive to meperidine or other analgesics for control of postoperative pain.Sedation in both children and adults, as well as relief of apprehension and production of light sleep from which the patient can be easily aroused.Active and prophylactic treatment of motion sickness.Antiemetic therapy in postoperative patients. This formulation utilizes a syrup delivery system. Marketed by Cranbury Pharmaceuticals, Llc, this product is identified by NDC 27808-051 and is authorized under FDA application ANDA091675.
Identification & Billing
- RxCUI: 992432 - promethazine HCl 6.25 MG in 5 mL Oral Solution
- RxCUI: 992432 - promethazine hydrochloride 1.25 MG/ML Oral Solution
- RxCUI: 992432 - promethazine HCl 6.25 MG per 5 ML Oral Syrup
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 27808 - Cranbury Pharmaceuticals, Llc
- 27808-051 - Promethazine Hydrochloride
- 27808-051-01 - 237 mL in 1 BOTTLE
- 27808-051 - Promethazine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (27808-051). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 27808-051-01 identifies a specific commercial package of 237 ml in 1 bottle of Promethazine Hydrochloride, a human prescription drug labeled by Cranbury Pharmaceuticals, Llc. This syrup is formulated for oral use and contains promethazine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cranbury Pharmaceuticals, Llc on June 08, 2012.
How is this Cranbury Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 27808005101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.